Thorlef Spickschen, Director at Clovis Oncology, Inc. (CLVS), sold 4,500 shares at $64.97 ($292K) on 2018-01-08, disclosed to the SEC on 2018-01-09.
Open-market sale of $292k CLVS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CLVS | SELL | 2018-04-09 | $270K | — | Filing → |
| CLVS | SELL | 2018-03-09 | $277K | — | Filing → |
| CLVS | SELL | 2018-02-23 | $270K | — | Filing → |